Acorda Therapeutics, Inc.

NASDAQ:ACOR

0.661 (USD) • At close April 11, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

202320222021202020192018201720162015201420132012201120102009200820072006200520042003
Operating Activities:
Net Income -252.854-65.916-103.954-99.594-272.96633.682-223.359-35.60311.05817.67216.441154.95830.605-11.769-83.94-74.341-37.974-24.019-35.53-44.741-25.734
Depreciation & Amortization 31.66632.80933.95341.29834.57311.47923.23421.58215.0128.4736.9994.6634.6253.9517.6930.446-0.6551.5831.8123.07-0.74
Deferred Income Tax -43.17730.669-5.1864.667-1.978-14.505-54.044-11.193.9756.6819.52-133.042-10.07400-7,796.601-3,844.465-3,844.557-4,371.9400
Stock Based Compensation 0.4781.4932.9958.114.2521.25232.81436.38633.46729.43725.13921.41819.30317.77712.2787,796.4763,844.5543,844.5544,371.9400
Change In Working Capital -10.8311.69824.935-11.954-41.40547.608-27.16315.229-25.494-4.176-21.117-0.29-8.728-33.497102.22712.3735.068-4.4589.1225.668-1.288
Accounts Receivables -3.4322.5853.1911.891.34757.972-29.112-19.9650.744-1.427-4.457-3.499-0.556-16.533-1.11750.518-3,726.847-3,726.8471,333.5860-0.214
Inventory -3.4035.7967.86-3.4563.7938.445.505-6.66-9.639-0.665-5.1247.42710.036-31.526-0.6192.733-1.5030.536-3.82-0.4230
Accounts Payables 0.884-7.3591.108-8.971-60.564-3.488-3.57137.625-0.82513.18-5.78511.743-6.10824,706.1992,224.9364,623.743-4,538.197-4,538.1977,428.8780-0.2
Other Working Capital -4.880.67612.776-1.41714.019-15.3160.0154.229-15.774-15.264-5.751-15.961-12.1-24,691.637-2,120.974-4,664.628,271.6158,260.05-8,749.5226.092-0.874
Other Non Cash Items 260.734-21.6775.909-3.523139.35951.277345.0188.9430.46316.9332.3034.41230.6054.3220.37712.4917.7963.4384.459.0643.273
Operating Cash Flow -13.984-20.924-41.348-61.006-128.167150.79396.535.34738.48175.0239.28552.11966.336-19.21638.634-49.155-25.677-23.46-20.147-26.939-24.49
Investing Activities:
Investments In Property Plant And Equipment -0.264-0.136-0.191-4.39-90.426-33.915-14.376-273.539-7.066-483.934-14.663-13.578-5.787-9.444-2.427-6.806-11.336-0.527-0.2-0.532-0.748
Acquisitions Net 0073.9690-89.9210.5870-267.3471.145478.8510.623.1943.5956.9981.27910,00000000
Purchases Of Investments 0000-226.587-249.1070-40.215-434.67-580.381-221.429-322.455-266.736-310.955-310.378-326.034-147.149-46.293-11.521-19.18-18.67
Sales Maturities Of Investments 00063.75316.50898.2730239.966356.5770.49191264.75227.5325.75296.4191.55107.7512.98618.73540.2849.249
Other Investing Activites 0073.94363.7589.9217.2973.663267.349-1.145-478.85-10.62-3.194-3.595-6.998-1.279-10,00000-3-20
Investing Cash Flow -0.264-0.13673.77859.36-0.505-176.865-10.713-73.786-85.236-293.825-45.092-71.283-45.0235.351-16.405-141.291-50.735-33.8354.01518.572-10.169
Financing Activities:
Debt Repayment 00-69.655-0.597-55.813-0.657-2.40900000-1.96200000000
Common Stock Issued 00000.02415.19810.47975.5218.09616.015003.9628.372.542205.05774.65961.910.0200
Common Stock Repurchased 0000-0.091-1.744-0.06000000-0.3290000000
Dividends Paid 00000-63.9280000000000-12,734.009-12,734.009-5,341.37300
Other Financing Activities 00-69.655-1.071-4.6763.92853.509-29.589-0.307336.92211.9683.0860-6.85-7.07-1.80912,734.47112,735.7335,357.51711.13155.966
Financing Cash Flow 00-69.655-1.668-60.5512.79761.51945.93117.789352.93711.9683.08621.191-4.528203.24875.12163.63416.16411.13155.966
Other Information:
Effect Of Forex Changes On Cash 0.1880.512-0.4471.0180.062-0.4121.225-2.15900.00100000000000
Net Change In Cash -14.06-20.548-37.672-2.296-189.16-13.687148.5315.333-28.966134.1336.161-16.07823.313-12.67417.70112.803-1.296.340.0322.76421.307
Cash At End Of Period 30.3644.67565.223102.895105.191294.351307.068158.537153.204182.1748.03741.87657.95434.64147.31429.61316.8118.10111.76111.72948.319